Andżelika Siwiec-Koźlik (@a_siwieckozlik) 's Twitter Profile
Andżelika Siwiec-Koźlik

@a_siwieckozlik

MD, @RheumKrakow, @JagiellonskiUni
Interests: #Rheumatology #Immunology #SLE #Sarcoidosis #Scleroderma #Thrombosis #InternalMedicine

ID: 1603834305502904320

linkhttps://orcid.org/0000-0003-2258-0248 calendar_today16-12-2022 19:28:13

158 Tweet

697 Takipçi

2,2K Takip Edilen

Rheumatology & Immunology, Jagiellonian University (@rheumkrakow) 's Twitter Profile Photo

#PsoriaticArthritis vs. #RheumatoidArthritis: Endothelial Dysfunction & CV Risk by Jarosław Nowakowski et al. 🔗 doi.org/10.1007/s00296… 🩸 Both PsA & RA ⬆️CV risk, but in different ways: ✅ PsA = early microvascular dysfunction & atherosclerosis ✅RA = more vascular remodeling &

#PsoriaticArthritis vs. #RheumatoidArthritis: Endothelial Dysfunction &amp; CV Risk by <a href="/JarosawNowakow6/">Jarosław Nowakowski</a> et al.
🔗 doi.org/10.1007/s00296…
🩸 Both PsA &amp; RA ⬆️CV risk, but in different ways:
✅ PsA = early microvascular dysfunction &amp; atherosclerosis
✅RA = more vascular remodeling &amp;
Rheumatology & Immunology, Jagiellonian University (@rheumkrakow) 's Twitter Profile Photo

🧐 Could #SLE increase #cancer risk? 👉doi.org/10.1007/s00296… 🔬 New study by Joanna Kosałka-Węgiel Andżelika Siwiec-Koźlik Mariusz Rheumatology & Immunology, Jagiellonian University et al. : ✅1 in 10 SLE patients develop malignancy—mostly solid tumors ✅Linked to older age at SLE onset & longer disease duration

🧐 Could #SLE increase #cancer risk?
👉doi.org/10.1007/s00296…
🔬 New study by <a href="/KaWegiel68670/">Joanna Kosałka-Węgiel</a> <a href="/A_SiwiecKozlik/">Andżelika Siwiec-Koźlik</a> <a href="/Mariusz1525972/">Mariusz</a> <a href="/RheumKrakow/">Rheumatology & Immunology, Jagiellonian University</a>  et al. : 
✅1 in 10 SLE patients develop malignancy—mostly solid tumors
✅Linked to older age at SLE onset &amp; longer disease duration
EMEUNET (@emeunet) 's Twitter Profile Photo

Meet Rheumavision Semi-Finalist Piotr Kuszmiersz and his presentation 'Beyond Inflammation in D2T axSpA' 👏👏👏 Full version: pulse.ly/ttjtjq8dwt Please don't forget to show your support by likes and comments!!! All the luck for the finals Piotr 🤞🤞🤞

Laurent ARNAUD (@lupusreference) 's Twitter Profile Photo

✅ Today, the pharmaceutical company Roche has publicly communicated (link: roche.com/media/releases…) that the US FDA had accepted their supplemental biologics license application to expand the indication of #obinutuzumab to #lupus #nephritis. This means...see thread...

Rheumatology & Immunology, Jagiellonian University (@rheumkrakow) 's Twitter Profile Photo

📢 Exciting news from our department! Our colleague Piotr Kuszmiersz is a RheumaVision Semi-Finalist with his presentation 'Beyond Inflammation in D2T axSpA' 🎉 Let’s show our support with likes and comments 👍 Wishing you all the best for the finals Piotr Kuszmiersz ! EMEUNET

Rheumatology & Immunology, Jagiellonian University (@rheumkrakow) 's Twitter Profile Photo

❄️ Our rheumatology team enjoyed a memorable integration trip to #Zakopane #TatraMountains welcomed not by blooming flowers, but by a fresh blanket of snow. From snowy hikes and warm dinners to great company and laughter, it was a perfect mix of nature, bonding, and relaxation.

❄️ Our rheumatology team enjoyed a memorable integration trip to #Zakopane  #TatraMountains welcomed not by blooming flowers, but by a fresh blanket of snow. From snowy hikes and warm dinners to great company and laughter, it was a perfect mix of nature, bonding, and relaxation.
Rheumatology & Immunology, Jagiellonian University (@rheumkrakow) 's Twitter Profile Photo

At the EuroSpA meeting in Copenhagen, Prof. Mariusz Korkosz and Dr. Piotr Kuszmiersz represented #PolNorRheuma — Poland’s first national #registry for #InflammatoryArthritis #AxSpA With data from 1,500+ patients, it contributes valuable real-world insights to the #EuroSpA

At the EuroSpA meeting in Copenhagen, Prof. Mariusz Korkosz and Dr. Piotr Kuszmiersz represented #PolNorRheuma — Poland’s first national #registry for #InflammatoryArthritis #AxSpA
With data from 1,500+ patients, it contributes valuable real-world insights to the #EuroSpA
Dr. John Cush (@rheumnow) 's Twitter Profile Photo

EMA has approved upadacitinib (Rinvoq) for use in the EU to treat adult patients with giant cell arteritis (GCA) - approval is based on data from the Phase 3 SELECT-GCA trial demonstrating sustained remission and key secondary endpoints buff.ly/MWV4DOg

EMA has approved upadacitinib (Rinvoq) for use in the EU to treat adult patients with giant cell arteritis (GCA) - approval is based on data from the Phase 3 SELECT-GCA trial demonstrating sustained remission and key secondary endpoints buff.ly/MWV4DOg
Armen Yuri Gasparyan (@armenyuri) 's Twitter Profile Photo

Work productivity and activity impairment in patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis: a comparative analysis from the POLNOR-Rheuma cohort Piotr Kuszmiersz Jarosław Nowakowski Zofia Rheumatology & Immunology, Jagiellonian University ASAS link.springer.com/article/10.100…

Armen Yuri Gasparyan (@armenyuri) 's Twitter Profile Photo

Tuberculosis is the predominant infection in systemic sclerosis: thirty-year retrospective study of serious infections from a single centre Scleroderma India Scleroderma News Scleroderma Canada SclerodermaRF APLAR RheumAFLAR pubmed.ncbi.nlm.nih.gov/39180530/

Rheumatology & Immunology, Jagiellonian University (@rheumkrakow) 's Twitter Profile Photo

We’re proud to share that the POL-DMARDs registry from the #POLNORRheuma project has officially joined the #EuroSpA network! 👏 Prof. Mariusz Korkosz & Dr Piotr Kuszmiersz from Jagiellonian University Medical College represented #Poland at the EuroSpA Scientific Committee

We’re proud to share that the POL-DMARDs registry from the #POLNORRheuma project has officially joined the #EuroSpA network! 👏 
Prof. Mariusz Korkosz &amp; Dr Piotr Kuszmiersz from Jagiellonian University Medical College represented #Poland at the EuroSpA Scientific Committee
Laurent ARNAUD (@lupusreference) 's Twitter Profile Photo

✅ Very honored to join my Gulf colleagues at the 3rd annual conference of the #Kuwait Association of #Rheumatologists. I will be talking about the (many) changes in the care of #lupus during the last decade, as well as about the (still very) long road ahead of us 🚑

✅ Very honored to join my Gulf colleagues at the 3rd annual conference of the #Kuwait Association of #Rheumatologists.
I will be talking about the (many) changes in the care of #lupus during the last decade, as well as about the (still very) long road ahead of us 🚑